The MD Anderson Cancer Center Madrid – Hospiten, a center specializing in comprehensive cancer care, has once again been included in the “World’s Best Specialized Hospitals 2027” ranking, compiled by Newsweek and Statista, and this represents one of the most prestigious distinctions in the healthcare sector.
This seventh edition identifies the world’s leading hospitals in 13 medical specialties, offering a comprehensive, international evaluation that takes into account the centers’ specialization and excellence in various fields. The specialties included are: Cardiac Surgery, Cardiology, Endocrinology, Gastroenterology, Nephrology (for the first time), Neurology, Neurosurgery, Obstetrics and Gynecology, Oncology, Orthopedics, Pediatrics, Pulmonology, and Urology.
This ranking is based on three independent pillars: recommendations from industry professionals, gathered through a global survey of medical specialists, including physicians, healthcare staff, and hospital administrators; verified accreditations and certifications held by the facilities; and the implementation of Patient-Reported Outcome Measures (PROMs). Together, these criteria enable the assessment and recognition of hospitals’ quality standards in terms of the quality of care provided, and reflect the facilities’ commitment to patient-centered care.
“Being included in this international ranking is a source of pride and great satisfaction for all of us at MD Anderson Madrid – Hospiten. This recognition attests to the excellence of our teams and our care model, as well as our ongoing effort to provide our patients with the highest quality cancer care, supported by specialization, innovation, and continuous improvement. We accept this distinction with satisfaction, but also as an incentive to keep moving forward,” says Dr. Santiago González Moreno, medical director of MD Anderson Madrid – Hospiten.
The hospital’s care model is based on a multidisciplinary and comprehensive approach to cancer, bringing together in a single setting the expertise of its specialized teams and the most advanced technologies in surgical oncology, precision radiation therapy, and systemic treatments—such as chemotherapy, molecularly targeted therapies, and immunotherapy. This capability is complemented by a Phase I Clinical Trials Unit, designed to facilitate access to innovative therapies and to promote new strategies in the areas of cancer prevention, diagnosis, and treatment, as well as by the Translational Research Laboratory, where world-class scientific projects are carried out. The center also has the backing of MD Anderson in Houston, one of the world’s leading institutions in cancer research and care, and is its only affiliate outside the United States.
The impact is particularly significant not only at the institutional level but also in terms of reputation, as these types of evaluations serve as a reference for patients and provide recognition for healthcare professionals and partners when evaluating centers and making decisions related to healthcare.
MD Anderson Madrid – Hospiten’s inclusion in the“World’s Best Specialized Hospitals 2027”ranking reinforces the center’s commitment to clinical excellence, quality of care, and patient-centered care focused on improving patients’ quality of life—fundamental pillars of its cancer care model—and highlights the hospital’s leadership in the field of specialized cancer care.
The ranking compiled by Newsweek and Statista can be viewed here.
This article is an English translation generated with AI from the original Spanish content. While we review content for clarity, the information is provided for general informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for diagnosis or treatment.